Lumos Diagnostics Holdings Limited (LDX.AX)

AUD 0.03

(13.64%)

EBITDA Summary of Lumos Diagnostics Holdings Limited

  • Lumos Diagnostics Holdings Limited's latest annual EBITDA in 2024 was -5.43 Million USD , down -10.29% from previous year.
  • Lumos Diagnostics Holdings Limited's latest quarterly EBITDA in 2024 Q4 was -842.25 Thousand USD , down -21.83% from previous quarter.
  • Lumos Diagnostics Holdings Limited reported an annual EBITDA of -4.92 Million USD in 2023, up 77.07% from previous year.
  • Lumos Diagnostics Holdings Limited reported an annual EBITDA of -18.67 Million USD in 2022, down -74.64% from previous year.
  • Lumos Diagnostics Holdings Limited reported a quarterly EBITDA of -2.19 Million USD for 2024 Q1, down -33.92% from previous quarter.
  • Lumos Diagnostics Holdings Limited reported a quarterly EBITDA of -2.19 Million USD for 2024 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Lumos Diagnostics Holdings Limited (2024 - 2018)

Historical Annual EBITDA of Lumos Diagnostics Holdings Limited (2024 - 2018)

Year EBITDA EBITDA Growth
2024 -5.43 Million USD -10.29%
2023 -4.92 Million USD 77.07%
2022 -18.67 Million USD -74.64%
2021 -10.69 Million USD -2.66%
2020 -10.41 Million USD -277.48%
2019 -2.75 Million USD -124.52%
2018 -1.22 Million USD 0.0%

Peer EBITDA Comparison of Lumos Diagnostics Holdings Limited

Name EBITDA EBITDA Difference
Australian Clinical Labs Limited 181.83 Million AUD 102.99%
BCAL Diagnostics Limited -5.66 Million AUD 4.073%
Genetic Signatures Limited -20.33 Million AUD 73.272%
Genetic Technologies Limited -11.43 Million AUD 52.444%
Healius Limited -298.09 Million AUD 98.176%
Imagion Biosystems Limited -13.69 Million AUD 60.312%
Integral Diagnostics Limited 12.33 Million AUD 144.073%
INOVIQ Ltd -6.63 Million AUD 18.051%
Microba Life Sciences Limited -22.8 Million AUD 76.167%
Monash IVF Group Limited 13.02 Million AUD 141.735%
Rhythm Biosciences Limited -6.79 Million AUD 20.011%
Sonic Healthcare Limited 1.65 Billion AUD 100.328%